← All trials

NCT05681806

N/AInterventional

Trials without FDA-defined phases, including trials of devices or behavioral interventions.

View on ClinicalTrials.gov ↗

Timeline

Start date
Feb 23, 2023
Primary completion
Aug 9, 2024
Completion date
Aug 26, 2024
First posted
Jan 12, 2023
Last posted
Oct 26, 2023
Enrollment
45
Arms / groups
3 / —
Source
AACT · ctgov ingestion

Sponsors

  • LonzaLead sponsor
  • LonzaReponsible party - principal investigator

Drugs studied

Indications studied

CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.